Endometrial cancer Clinical Trials in Raleigh, NC
As of June 2026, 2 paid clinical trials are recruiting for Endometrial cancer in Raleigh, North Carolina. Recruiting Endometrial cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Raleigh
Filter results
2 clinical trials for Endometrial cancer
·Clear filters·↓ Download CSVAdjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
About research studies in Raleigh
Raleigh has approximately 204 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Top Research Study Locations in Raleigh
Researchers run research studies in Raleigh, NC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Duke Cancer Center Raleigh | Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8 | 18 |
| Duke Women's Cancer Care Raleigh | Recurrent Endometrial Carcinoma, Breast Cancer, Anatomic Stage I Breast Cancer AJCC v8 | 18 |
| WakeMed | End Stage Renal Disease, Heart Failure, Hemodialysis Access Failure | 11 |
| NC Heart and Vascular Research, LLC | Coronary Artery Disease, Cardiovascular Diseases, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities | 9 |
| NC Heart and Vascular Research | Heart Failure, Iliofemoral; Thrombosis, Acute Myocardial Infarction (AMI) | 7 |
| UNC Health Cancer Care Raleigh | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia | 7 |
| UNC Health Cancer Care Wakefield | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Acute Lymphoblastic Leukemia | 7 |
| WakeMed Health & Hospitals | Intubation Complication, Child Social-Emotional Development, Epigenetic Aging | 5 |
| Associated Urologists of North Carolina | Benign Prostatic Hyperplasia, Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-Muscle Invasive Bladder Neoplasms | 4 |
| Duke Raleigh Hospital | Atherosclerosis of Extremities, Cancer of the Prostate, Hormone Sensitive Prostate Cancer | 4 |
| North Carolina State University | Alzheimer Disease, Blood Pressure, Diabetes Mellitus Risk | 4 |
| Accellacare of Raleigh | Atherosclerotic Cardiovascular Disease, Diabetes Mellitus, Type 1, Obesity | 3 |
| M3 Wake Research, Inc | Irritable Bowel Syndrome With Constipation (IBS-C), Metabolic Dysfunction-Associated Steatohepatitis, Obesity Associated With Defects in Leptin-melanocortin Pathway | 3 |
| M3 Wake Research, Inc. | Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis, Metabolic Dysfunction Associated Steatohepatitis (MASH) | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Carolina Women's Research and Wellness Center | Pregnancy Prevention | 2 |
| ClinTrial Research, LLC - Site Number: 8400043 | Crohn's Disease, Ulcerative Colitis | 2 |
| Eximia Research - Raleigh | Diabetic Peripheral Neuropathic Pain | 2 |
| NC Heart and Vascular | Coronary Artery Disease, Hypertension | 2 |
| NC State University | Diet Interventions, Food Security, Fruit and Vegetable Intake | 2 |
| North Carolina Clinical Research | Asthma, Celiac Disease | 2 |
| North Carolina Nephrology, PA | Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease in Patients With ESKD, End Stage Kidney Disease | 2 |
| Raleigh Neurology Associates- Site Number : 8400043 | Chronic Inflammatory Demyelinating Polyneuropathy, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Polyneuropathy, Inflammatory Demyelinating, Chronic | 2 |
| Rex Healthcare | Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, Leukemia | 2 |
| TG Therapeutics Investigational Trial Site | Relapsing Multiple Sclerosis, Multiple Sclerosis | 2 |
Active & Upcoming Studies in Raleigh (2026)
Recruiting trials in Raleigh grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (49 active studies)
- Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer · Phase 2 · National Cancer Institute (NCI)
- Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · Phase 3 · National Cancer Institute (NCI)
Cardiovascular (23 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- CRF2 Agonist for the Treatment of Worsening Heart Failure · Phase 2 · Corteria Pharmaceuticals
Neurology & pain (18 active studies)
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis · Phase 3 · Zenas BioPharma (USA), LLC
- Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures · Phase 3 · Praxis Precision Medicines
Diabetes & metabolic (13 active studies)
Mental health & behavior (3 active studies)
- A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers · RAI Services Company
- Effect of Flavored on!® Nicotine Pouch Products on Smoking Behaviors: a SMART Study · Altria Client Services LLC
Pediatric (2 active studies)
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
- Optimizing Tracheal Intubation Outcomes and Neonatal Safety · Children's Hospital of Philadelphia
Common conditions studied in Raleigh
- Heart Failure (9 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- Coronary Artery Disease (5 active studies). Coronary artery disease research evaluates lipid-lowering therapies, anti-inflammatory agents, and new revascularization devices.
- Obesity (5 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Breast Cancer (4 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Recurrent Endometrial Carcinoma (4 active studies). ENT (otolaryngology) trials evaluate new treatments for hearing loss, swallowing disorders, and head and neck cancers — covering pharmacologic, surgical, and rehabilitative approaches.
- Stroke (4 active studies). Stroke trials test acute reperfusion strategies, neuroprotective agents, and rehabilitation technologies to improve recovery.
Leading research sponsors in Raleigh
- National Cancer Institute (NCI)
- North Carolina State University
- NRG Oncology
- Alliance for Clinical Trials in Oncology
- AstraZeneca
Local regulations and guidelines
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Raleigh. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Raleigh
Hipa.ai aggregates every recruiting study in Raleigh from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Raleigh?
There are approximately 204 recruiting clinical trials in Raleigh, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Raleigh pay participants?
Most recruiting trials in Raleigh compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Raleigh?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Raleigh?
The most common conditions under active study in Raleigh include Heart Failure (9), Coronary Artery Disease (5), Obesity (5), Breast Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Raleigh?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Raleigh on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Raleigh?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Raleigh?
Recruiting research sites in Raleigh include Duke Cancer Center Raleigh, Duke Women's Cancer Care Raleigh, WakeMed, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Raleigh right now?
The largest active categories in Raleigh are Cancer & tumors (49), Cardiovascular (23), Neurology & pain (18). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.